Literature DB >> 8138763

Randomised controlled trial in northern England of the effect of a person knowing their own serum cholesterol concentration.

P J Elton1, A Ryman, M Hammer, F Page.   

Abstract

SUBJECT
OBJECTIVE: To test the hypotheses that the knowledge that the serum cholesterol concentration is raised (> or = 6.5 mmol/l) will lead to a reduction in the concentration after education intervention and that the knowledge that the concentration is not raised does not lead to an increase in the serum cholesterol concentration after education intervention.
DESIGN: Prospective randomised trial, with investigators blind to the randomisation.
SETTING: An industrial site in Manchester, England. PARTICIPANTS: A total of 495 employees of Imperial Chemical Industries, 469 of whom completed the trial. MAIN RESULT: There was a significant reduction in the serum cholesterol concentration of those whose initial concentration was > or = 6.5 mmol/l and who were given the result. This reduction was 0.28 mmol/l greater than in the control group. The reduction was similar, however, to the increase in the serum cholesterol concentration in those whose initial concentration was < 5.2 mmol/l, regardless of whether or not they had been given the result.
CONCLUSION: These results support the hypotheses, although the lack of regression to the mean in the control group with high serum cholesterol suggests that this conclusion should be treated with caution.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8138763      PMCID: PMC1059887          DOI: 10.1136/jech.48.1.22

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  21 in total

1.  Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.

Authors:  W B Kannel; W P Castelli; T Gordon; P M McNamara
Journal:  Ann Intern Med       Date:  1971-01       Impact factor: 25.391

2.  Fluctuating serum cholesterol: implications for coronary prevention.

Authors:  B H Natelson; W N Tapp; A Munsif; W Burns
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321

3.  Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

Authors:  M J Martin; S B Hulley; W S Browner; L H Kuller; D Wentworth
Journal:  Lancet       Date:  1986-10-25       Impact factor: 79.321

4.  Strategies for reducing coronary heart disease and desirable limits for blood lipid concentrations: guidelines of the British Hyperlipidaemia Association.

Authors:  J Shepherd; D J Betteridge; P Durrington; M Laker; B Lewis; J Mann; J P Miller; J P Reckless; G R Thompson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-14

5.  The resurgence of malaria. Diagnostic and therapeutic dilemmas.

Authors:  T C Quinn; J J Plorde
Journal:  Arch Intern Med       Date:  1981-08

6.  Seasonal cholesterol cycles: the Lipid Research Clinics Coronary Primary Prevention Trial placebo group.

Authors:  D J Gordon; D C Trost; J Hyde; F S Whaley; P J Hannan; D R Jacobs; L G Ekelund
Journal:  Circulation       Date:  1987-12       Impact factor: 29.690

7.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Authors:  M H Frick; O Elo; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen; V Manninen
Journal:  N Engl J Med       Date:  1987-11-12       Impact factor: 91.245

8.  Motivational effect of cholesterol measurement in general practice health checks.

Authors:  I Robertson; A Phillips; D Mant; M Thorogood; G Fowler; A Fuller; P Yudkin; M Woods
Journal:  Br J Gen Pract       Date:  1992-11       Impact factor: 5.386

9.  Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease.

Authors:  S J Pocock; A G Shaper; A N Phillips
Journal:  BMJ       Date:  1989-04-15

10.  Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study.

Authors:  O Turpeinen; M J Karvonen; M Pekkarinen; M Miettinen; R Elosuo; E Paavilainen
Journal:  Int J Epidemiol       Date:  1979-06       Impact factor: 7.196

View more
  5 in total

1.  Cholesterol and coronary heart disease: screening and treatment.

Authors:  S Ebrahim; G D Smith; C McCabe; N Payne; M Pickin; T A Sheldon; F Lampe; F Sampson; S Ward; G Wannamthee
Journal:  Qual Health Care       Date:  1998-12

2.  Assessing quality of a worksite health promotion programme from participants' views: findings from a qualitative study in Malaysia.

Authors:  Siow-Yen Liau; Mohamed-Azmi A Hassali; Asrul A Shafie; Mohamed-Izham M Ibrahim
Journal:  Health Expect       Date:  2011-11-03       Impact factor: 3.377

3.  Using body mass index data in the electronic health record to calculate cardiovascular risk.

Authors:  Beverly B Green; Melissa L Anderson; Andrea J Cook; Sheryl Catz; Paul A Fishman; Jennifer B McClure; Robert Reid
Journal:  Am J Prev Med       Date:  2012-04       Impact factor: 5.043

4.  Effectiveness and uptake of screening programmes for coronary heart disease and diabetes: a realist review of design components used in interventions.

Authors:  Carol Holland; Yvonne Cooper; Rachel Shaw; Helen Pattison; Richard Cooke
Journal:  BMJ Open       Date:  2013-11-07       Impact factor: 2.692

Review 5.  Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature.

Authors:  Stacey L Sheridan; Eric Crespo
Journal:  BMC Health Serv Res       Date:  2008-03-20       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.